Public Health Informatics Graduate Program at University of Maryland
Biohealthmatics Centers
Jobs Search
Career Center
Networking Center
Company Profiles
Knowledge Center
Industry News
Web Directory
Industry Books
Featured Articles professionals

Join Us

Link To Us

Healthcare IT and Biotechnology News Release
Date of Publication: Friday, February 17, 2006

Millenia Hope Acquires Cutting-Edge Biopharma Platform

Millenia Subsidiary to Commercialize Unique Technology
WILMINGTON, Del. -- Millenia Hope Inc., a biopharma corporation (BULLETIN BOARD: MLHP) , is pleased to announce that its Canadian subsidiary, Millenia Hope Biopharma (MH-B), has purchased the Intellectual property, scientific expertise and the research facilities of the former Avance Pharma.

Avance Pharma is one of the world's leading bio-research firms in Phytomic Technology, the commercialization of plant cell cultures. Avance has spent over $30 million in creating its unique technology, including the world's largest collection of highly purified phyto-chemical fractions to be utilized in the pharmaceutical, cosmetic and nutraceutical industry. Because of its cutting-edge technology, Avance Pharma has been the recipient of several R&D grants.

MH-B, retaining Avance's world-class research personnel and all of its operating assets and facilities, is diligently working to complete the initial commercialization of several projects with leading multi-national corporations. These projects will produce immediate revenues, milestone payments and future royalties, based on their specific criteria.

Other News Items Published on the Friday, February 17, 2006




Copyright © 2010 All Rights Reserved. Contact Us - About Us - Privacy Policy - Terms & Conditions - Resources
Can't find what you are looking for? View our Site Map

Also try visiting for more career resources

Proudly supports TDS Platform- An Online e-Health Platform

Last Updated: 24 November 2007.